Robert J. Spiegel Geron Corp (GERN) insider trading activity

GERN Quotes by TradingView

Robert J. Spiegel is Director of GERON CORP. Currently has a direct ownership of 182,844 shares of GERN, which is worth approximately $246,839. The most recent transaction as insider was on Jun 30, 2025, when has been sold 5,540 shares (Common Stock) at a price of $1.41 per share, resulting in proceeds of $7,811. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 183K
3.12% 3M change
8.57% 12M change
Total Value Held $246,839

Robert J. Spiegel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2025
BUY
Grant, award, or other acquisition
$7,811 $1.41 p/Share
5,540 Added 2.94%
182,844 Common Stock
Mar 31 2025
BUY
Grant, award, or other acquisition
$7,811 $1.59 p/Share
4,913 Added 2.7%
177,304 Common Stock
Dec 31 2024
SELL
Grant, award, or other acquisition
-
2,206 Reduced 1.26%
172,391 Common Stock
Sep 30 2024
SELL
Grant, award, or other acquisition
-
1,767 Reduced 1.03%
170,185 Common Stock
Jun 28 2024
SELL
Grant, award, or other acquisition
-
1,916 Reduced 1.12%
168,418 Common Stock
Mar 29 2024
SELL
Grant, award, or other acquisition
-
2,462 Reduced 1.46%
166,502 Common Stock
Dec 29 2023
BUY
Grant, award, or other acquisition
-
3,406 Added 2.03%
164,040 Common Stock
Sep 29 2023
BUY
Grant, award, or other acquisition
-
3,390 Added 2.07%
160,634 Common Stock
Jun 30 2023
BUY
Grant, award, or other acquisition
-
2,239 Added 1.4%
157,244 Common Stock
Mar 31 2023
BUY
Grant, award, or other acquisition
-
3,312 Added 2.09%
155,005 Common Stock
Dec 30 2022
BUY
Grant, award, or other acquisition
-
2,970 Added 1.92%
151,693 Common Stock
Sep 30 2022
BUY
Grant, award, or other acquisition
-
3,071 Added 2.02%
148,723 Common Stock
Jun 30 2022
BUY
Grant, award, or other acquisition
-
4,637 Added 3.09%
145,652 Common Stock
Mar 31 2022
BUY
Grant, award, or other acquisition
-
5,284 Added 3.61%
141,015 Common Stock
Dec 31 2021
BUY
Grant, award, or other acquisition
-
5,891 Added 4.16%
135,731 Common Stock
Sep 30 2021
BUY
Grant, award, or other acquisition
-
5,246 Added 3.88%
129,840 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
-
5,097 Added 3.93%
124,594 Common Stock
Mar 31 2021
BUY
Grant, award, or other acquisition
-
4,549 Added 3.67%
119,497 Common Stock
Dec 31 2020
BUY
Grant, award, or other acquisition
-
4,520 Added 3.78%
114,948 Common Stock
Sep 30 2020
BUY
Grant, award, or other acquisition
-
4,130 Added 3.61%
110,428 Common Stock

Also insider at

AYLA
Ayala Pharmaceuticals, Inc. Healthcare
Director
CYCC
Cyclacel Pharmaceuticals, Inc. Healthcare
Director
ATNX
Athenex, Inc. Healthcare
Director
ADXSD
Advaxis, Inc.
Director
RNXT
RenovoRx, Inc. Healthcare
Director
RJS

Robert J. Spiegel

Director
Buffalo, NY

Track Institutional and Insider Activities on GERN

Follow GERON CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GERN shares.

Notify only if

Insider Trading

Get notified when an Geron Corp insider buys or sells GERN shares.

Notify only if

News

Receive news related to GERON CORP

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GERN